Abstract:Alzheimer's disease (AD) is a chronic neurodegenerative, and abnormal aggregation of the neurotoxic beta amyloid (A beta) peptide is an early event in AD. The present study aimed to determine the correlation between the nicotinic acetylcholine receptor alpha 7 subunit (alpha 7 nAChR) and A beta in the brains of patients with AD, and to investigate whether the increased expression levels of the alpha 7 nAChR could alter the neurotoxicity of A beta. The expression levels of alpha 7 nAChR and A beta in the brains of patients with AD and healthy brains were analyzed using immunofluorescence. Moreover, SH-SY5Y cells were used to stably overexpress or silence alpha 7 nAChR expression levels, prior to the treatment with or without 1 mu mol/l A beta(1-42) oligomer (A beta O). The mRNA and protein expression levels of alpha 7 nAChR, synaptophysin (SYP), postsynaptic density of 95 kDa (PSD-95) and synaptosomal-associated protein of 25 kDa (SNAP-25) were subsequently analyzed using reverse transcription-quantitative PCR and western blotting. In addition, the concentration of acetylcholine (ACh) and the activity of acetylcholinesterase (AChE) were analyzed using spectrophotometry, while the cell apoptotic rate was determined using flow cytometry. The expression of A beta in the brains of patients with AD was found to be significantly increased, whereas the expression of alpha 7 nAChR was significantly decreased compared with the healthy control group. In vitro, the expression levels of alpha 7 nAChR were significantly increased or decreased following the overexpression or silencing of the gene, respectively. Consistent with these observations, the mRNA and protein expression levels of SYP, PSD-95 and SNAP-25 were also significantly increased following the overexpression of alpha 7 nAChR and decreased following the genetic silencing of the receptor. In untransfected or negative control cells, the expression levels of these factors and the apoptotic rate were significantly reduced following the exposure to A beta O, which was found to be attenuated by alpha 7 nAChR overexpression, but potentiated by alpha 7 nAChR RNA silencing. However, no significant differences were observed in either the ACh concentration or AChE activity following transfection. Collectively, these findings suggested that alpha 7 nAChR may protect the brains of patients with AD against A beta, as alpha 7 nAChR overexpression increased the expression levels of SYP, SNAP-25 and PSD-95, and attenuated the inhibitory effect of A beta on the expression of these synaptic proteins and cell apoptosis. Overall, this indicated that alpha 7 nAChR may serve an important neuroprotective role in AD.

Oxidative Stress Induced by Beta-Amyloid Peptide1–42 is Involved in the Altered Composition of Cellular Membrane Lipids and the Decreased Expression of Nicotinic Receptors in Human SH-SY5Y Neuroblastoma Cells

[Influence of Beta-Amyloid Peptide on Cell Membrane Lipids and Cholinergic Receptors in Human Neuroblastoma SH-SY5Y Cells].

Loss of Nicotinic Receptors Induced by Beta‐amyloid Peptides in PC12 Cells: Possible Mechanism Involving Lipid Peroxidation

Influence of Β-Amyloid Peptide on Expressions of Synaptophysin, Dynamin Ⅰ and Adaptor Protein 180 in Human Neuroblastoma SH-SYSY Cells

Changes In Mitochondrial Dynamics During Amyloid Beta-Induced Pc12 Cell Apoptosis

Preventing Expression Of The Nicotinic Receptor Subunit Alpha 7 In Sh-Sy5y Cells With Interference Rna Indicates That This Receptor May Protect Against The Neurotoxicity Of A Beta

Oxidative Stress Induces DNA Demethylation and Histone Acetylation in SH-SY5Y Cells: Potential Epigenetic Mechanisms in Gene Transcription in Aβ Production

Amyloid Β-42 Induces Neuronal Apoptosis by Targeting Mitochondria

Amyloid-Beta(1-42) Induces Reactive Oxygen Species-Mediated Autophagic Cell Death in U87 and Sh-Sy5y Cells

Aβ1-42 peptide toxicity on neuronal cells: A lipidomic study

Aβ induces astrocytic glutamate release, extrasynaptic NMDA receptor activation, and synaptic loss

[Influence of Inhibited Α7 Nicotinic Acetylcholine Receptor Gene Expression on the Production of Β-Amyloid Peptide in SH-SY5Y Cells].

Preventing Expression of the Nicotinic Receptor Subunit α7 in SH-SY5Y Cells with Interference RNA Indicates that this Receptor may Protect Against the Neurotoxicity of Aβ

IRE1α-XBP1 Affects the Mitochondrial Function of Aβ25–35-Treated SH-SY5Y Cells by Regulating Mitochondria-Associated Endoplasmic Reticulum Membranes

Expression levels of the 7 nicotinic acetylcholine receptor in the brains of patients with Alzheimer's disease and their effect on synaptic proteins in SH-SY5Y cells

P3–349: Inhibition of Secreted Alpha–app and Enhanced Neurotoxication of Beta–amyloid Peptide by Interference of Nicotinic Receptor Alpha7 Mrna in SH–SY5Y Cells

Effect of Beta-Amyloid Peptides on Alpha-7 Nicotinic Receptor Status in Astrocytes and Neurons, and Its Relationship to Pathogenesis of Alzheimer's Disease

The Effects Of Amyloid-Beta(42) Oligomer On The Proliferation And Activation Of Astrocytes In Vitro

The consequences of reducing expression of the α7 nicotinic receptor by RNA interference and of stimulating its activity with an α7 agonist in SH-SY5Y cells indicate that this receptor plays a neuroprotective role in connection with the pathogenesis of Alzheimer's disease

Damage to nicotinic acetylcholine receptors induced by amyloid beta-peptide 25 -35 in patients with primary Alzheimer disease

Acteoside protects human neuroblastoma SH-SY5Y cells against beta-amyloid-induced cell injury.